Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. Ca Cancer J Clin 71, 7–33 (2021).

Article  PubMed  Google Scholar 

Llovet, J. M. et al. Hepatocellular carcinoma. Nature Reviews Disease Primers 7, 6 (2021). https://doi.org/10.1038/s41572-020-00240-3

Article  PubMed  Google Scholar 

Son, B. et al. The role of tumor microenvironment in therapeutic resistance. Oncotarget 8, 3933 (2017).

Article  PubMed  Google Scholar 

Choi, B., Choi, H., Yu, B. & Kim, D.-H. Synergistic Local Combination of Radiation and Anti-Programmed Death Ligand 1 Immunotherapy Using Radiation-Responsive Splintery Metallic Nanocarriers. ACS Nano 14, 13115–13126 (2020). https://doi.org/10.1021/acsnano.0c04701

Article  PubMed  Google Scholar 

Kim, D.-H. Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma. Journal of Liver Cancer 22, 93–102 (2022). https://doi.org/10.17998/jlc.2022.03.28

Article  PubMed  PubMed Central  Google Scholar 

Lee, S., Ko, M. J., Avritscher, R., Lewandowski, R. J. & Kim, D.-H. Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors. ACS Nano 18, 24269–24282 (2024). https://doi.org/10.1021/acsnano.4c05809

Article  PubMed  Google Scholar 

Sas, Z., Cendrowicz, E., Weinhäuser, I. & Rygiel, T. P. Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options. International Journal of Molecular Sciences 23, 3778 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Birbrair, A. Tumor Microenvironments in Organs From the Brain to the Skin-Part B. Vol. 1226 227–247 (Springer, 2020).

Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nature reviews Clinical oncology 14, 749–762 (2017).

Article  PubMed  Google Scholar 

Xue, C., Zhou, Q., Xi, H. & Zhou, J. Radiomics: a review of current applications and possibilities in the assessment of tumor microenvironment. Diagnostic and Interventional Imaging 104, 113–122 (2023).

Article  PubMed  Google Scholar 

Murakami, W. et al. Correlation between 18F-FDG uptake on PET/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer. European Journal of Radiology 123, 108773 (2020).

Article  PubMed  Google Scholar 

Galon, J., Dieu-Nosjean, M., Tartour, E., Sautes-Fridman, C. & Fridman, W. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29, 1093–1102 (2010).

Article  PubMed  Google Scholar 

Yu, B., Kwak, K., Lewandowski, R. J. & Kim, D.-H. Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 35, 1033–1042.e1011 (2024). https://doi.org/10.1016/j.jvir.2024.03.014

Article  PubMed  Google Scholar 

Kim, H. et al. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo-Immuno-Embolization for the Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials 12, 2300906 (2023). https://doi.org/10.1002/adhm.202300906

Article  PubMed  PubMed Central  Google Scholar 

Choi, B., Pe, J., Yu, B. & Kim, D.-H. Syngeneic N1-S1 Orthotopic Hepatocellular Carcinoma in Sprague Dawley Rat for the Development of Interventional Oncology-Based Immunotherapy: Survival Assay and Tumor Immune Microenvironment. Cancers 15, 913 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Sun, R. et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. The Lancet Oncology 19, 1180–1191 (2018).

Article  PubMed  Google Scholar 

Chen, S. et al. Pretreatment prediction of Immunoscore in hepatocellular cancer: a radiomics-based clinical nomogram based on GdEOB-DTPA enhanced-MRI. Cancer 1 (2018).

Liao, H. et al. Preoperative radiomic approach to evaluate tumor-infiltrating CD8 + T cells in hepatocellular carcinoma patients using contrast-enhanced computed tomography. Annals of surgical oncology 26, 4537–4547 (2019).

Article  PubMed  Google Scholar 

Tian, Y. et al. Assessing PD-L1 expression level via preoperative MRI in HCC based on integrating deep learning and radiomics features. Diagnostics 11, 1875 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Hectors, S. J. et al. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma. European radiology 30, 3759–3769 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wu, C. et al. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. The Journal of clinical investigation 130, 4679–4693 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Peng, K. et al. Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma. Frontiers in Immunology 15, 1493735 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Wu, J. et al. A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma. Phenomics 3, 549–564 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Kang, W. et al. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis. Journal of Translational Medicine 21, 598 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Garnelo, M. et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut, gutjnl-2015-310814 (2015).

Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612, 141–147 (2022).

Article  PubMed  Google Scholar 

Kairaluoma, V., Kemi, N., Pohjanen, V.-M., Saarnio, J. & Helminen, O. Tumour budding and tumour–stroma ratio in hepatocellular carcinoma. British Journal of Cancer 123, 38–45 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Dominiak, A., Chełstowska, B., Olejarz, W. & Nowicka, G. (2020).

Bouattour, M., Mehta, N., He, A. R., Cohen, E. I. & Nault, J.-C. Systemic treatment for advanced hepatocellular carcinoma. Liver cancer 8, 341–358 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Brown, Z. J., Greten, T. F. & Heinrich, B. Adjuvant treatment of hepatocellular carcinoma: prospect of immunotherapy. Hepatology 70, 1437–1442 (2019).

Article  PubMed  Google Scholar 

Zongyi, Y. & Xiaowu, L. Immunotherapy for hepatocellular carcinoma. Cancer letters 470, 8–17 (2020).

Article  PubMed  Google Scholar 

Gong, X.-Q. et al. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma. Scientific Reports 13, 7710 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Yuan, G. et al. Development and validation of a contrast-enhanced CT-based radiomics nomogram for prediction of therapeutic efficacy of anti-PD-1 antibodies in advanced HCC patients. Frontiers in immunology 11, 613946 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Cui, H. et al. Radiomics signature based on CECT for non-invasive prediction of response to anti-PD-1 therapy in patients with hepatocellular carcinoma. Clinical Radiology 78, e37-e44 (2023).

Article  PubMed  Google Scholar 

Finn, R. S. et al. Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. Journal of Clinical Oncology 38, 2960 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Xu, B. et al. Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study. Liver Cancer 12, 262–276 (2023).

Article  PubMed  Google Scholar 

Hua, Y. et al. Pretreatment CT-based machine learning radiomics model